Sepsis & infection

Performance of sequential organ failure assessment 1 versus 2 for sepsis identification in patients with suspected infection: a multicenter retrospective cohort study

Crit CarePublished Retrospective cohort study

Authors' conclusion

SOFA-2-based sepsis identified a clinically meaningful higher-risk subgroup, with consistent results across sensitivity analyses.

Study context

Population
Patients with suspected infection, Chinese multicentre cohort, validated in the MIMIC-IV databaseChinese multicentre cohort
Participants
24,510 patients
Exposure
Sequential Organ Failure Assessment (SOFA-2) vs SOFA-1 definition for sepsis identification
  • SOFA-1(+)/SOFA-2(+)n = 18,179
Outcome
In-hospital mortality (discrimination and association by SOFA concordance category)
Methodological detailsmulticentre, external validation in MIMIC-IV database
  • Multicentre
  • External validation in MIMIC-IV database

Main finding

As reported in the abstract

In-hospital mortality
Each group vs SOFA-1(-)/SOFA-2(-)Hazard ratio (95% CI)
SOFA-1(+)/SOFA-2(-)
0.99(0.72–1.36)
SOFA-1(-)/SOFA-2(+)
3.52(2.66–4.67)
SOFA-1(+)/SOFA-2(+)
4.44(3.52–5.60)

Observational data: associations, not effects.

Further findings

OutcomeValues
Discrimination for in-hospital mortality (AUROC)SOFA-2 AUROC 0.746 (95% CI 0.737–0.756) · SOFA-1 AUROC 0.679 (95% CI 0.668–0.689)
Distribution of SOFA concordance categoriesSOFA-1(+)/SOFA-2(+) 74.2% (95% CI 73.6%–74.7%) · SOFA-1(+)/SOFA-2(-) 9.9% (95% CI 9.53%–10.2%) · SOFA-1(-)/SOFA-2(+) 5.5% (95% CI 5.2%–5.8%) · SOFA-1(-)/SOFA-2(-) 10.2% (95% CI 9.8%–10.6%)

Distribution of SOFA concordance categories

SOFA-1(-)/SOFA-2(+) patients younger, more often male, higher rates of pneumonia, gastrointestinal and neurologic infection

Original publication

Performance of sequential organ failure assessment 1 versus 2 for sepsis identification in patients with suspected infection: a multicenter retrospective cohort study. Crit Care. Published 26 April 2026. doi:10.1186/s13054-026-05981-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.